The global Tuberculosis Vaccines market was valued at US$ 76 million in 2022 and is projected to reach US$ 92 million by 2029, at a CAGR of 2.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccines. This report contains market size and forecasts of Tuberculosis Vaccines in global, including the following market information:
- Global Tuberculosis Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Tuberculosis Vaccines Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Tuberculosis Vaccines companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immunotherapeutic Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis Vaccines include Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals and Bavarian Nordic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tuberculosis Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Tuberculosis Vaccines Market Segment Percentages, by Type, 2022 (%)
- Immunotherapeutic Vaccines
- Booster Vaccines
- Others
Global Tuberculosis Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Tuberculosis Vaccines Market Segment Percentages, by Application, 2022 (%)
Global Tuberculosis Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Tuberculosis Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Tuberculosis Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Tuberculosis Vaccines revenues share in global market, 2022 (%)
- Key companies Tuberculosis Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
- Key companies Tuberculosis Vaccines sales share in global market, 2022 (%)
key players include:
- Sanofi
- Merck
- Serum Institute of India
- GlaxoSmithKline
- Japan BCG Lab
- IDT Biologics
- GreenSignal Bio Pharma
- Taj Pharmaceuticals
- Bavarian Nordic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tuberculosis Vaccines, market overview.
Chapter 2: Global Tuberculosis Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tuberculosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tuberculosis Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Vaccines Overall Market Size
2.1 Global Tuberculosis Vaccines Market Size: 2022 VS 2029
2.2 Global Tuberculosis Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tuberculosis Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Tuberculosis Vaccines Players in Global Market
3.2 Top Global Tuberculosis Vaccines Companies Ranked by Revenue
3.3 Global Tuberculosis Vaccines Revenue by Companies
3.4 Global Tuberculosis Vaccines Sales by Companies
3.5 Global Tuberculosis Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tuberculosis Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tuberculosis Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Vaccines Market Size Markets, 2022 & 2029
4.1.2 Immunotherapeutic Vaccines
4.1.3 Booster Vaccines
4.1.4 Others
4.2 By Type - Global Tuberculosis Vaccines Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Tuberculosis Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Tuberculosis Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Tuberculosis Vaccines Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Vaccines Sales, 2018-2023
4.3.2 By Type - Global Tuberculosis Vaccines Sales, 2024-2029
4.3.3 By Type - Global Tuberculosis Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Tuberculosis Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Tuberculosis Vaccines Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Tuberculosis Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Tuberculosis Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Tuberculosis Vaccines Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Vaccines Sales, 2018-2023
5.3.2 By Application - Global Tuberculosis Vaccines Sales, 2024-2029
5.3.3 By Application - Global Tuberculosis Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Tuberculosis Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Tuberculosis Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Tuberculosis Vaccines Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Tuberculosis Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Tuberculosis Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Tuberculosis Vaccines Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Vaccines Sales, 2018-2023
6.3.2 By Region - Global Tuberculosis Vaccines Sales, 2024-2029
6.3.3 By Region - Global Tuberculosis Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Tuberculosis Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Tuberculosis Vaccines Sales, 2018-2029
6.4.3 US Tuberculosis Vaccines Market Size, 2018-2029
6.4.4 Canada Tuberculosis Vaccines Market Size, 2018-2029
6.4.5 Mexico Tuberculosis Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Tuberculosis Vaccines Sales, 2018-2029
6.5.3 Germany Tuberculosis Vaccines Market Size, 2018-2029
6.5.4 France Tuberculosis Vaccines Market Size, 2018-2029
6.5.5 U.K. Tuberculosis Vaccines Market Size, 2018-2029
6.5.6 Italy Tuberculosis Vaccines Market Size, 2018-2029
6.5.7 Russia Tuberculosis Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Tuberculosis Vaccines Market Size, 2018-2029
6.5.9 Benelux Tuberculosis Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Tuberculosis Vaccines Sales, 2018-2029
6.6.3 China Tuberculosis Vaccines Market Size, 2018-2029
6.6.4 Japan Tuberculosis Vaccines Market Size, 2018-2029
6.6.5 South Korea Tuberculosis Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Tuberculosis Vaccines Market Size, 2018-2029
6.6.7 India Tuberculosis Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Tuberculosis Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Tuberculosis Vaccines Sales, 2018-2029
6.7.3 Brazil Tuberculosis Vaccines Market Size, 2018-2029
6.7.4 Argentina Tuberculosis Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Tuberculosis Vaccines Sales, 2018-2029
6.8.3 Turkey Tuberculosis Vaccines Market Size, 2018-2029
6.8.4 Israel Tuberculosis Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Tuberculosis Vaccines Market Size, 2018-2029
6.8.6 UAE Tuberculosis Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Tuberculosis Vaccines Major Product Offerings
7.1.4 Sanofi Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Tuberculosis Vaccines Major Product Offerings
7.2.4 Merck Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Vaccines Major Product Offerings
7.3.4 Serum Institute of India Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Tuberculosis Vaccines Major Product Offerings
7.4.4 GlaxoSmithKline Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Japan BCG Lab
7.5.1 Japan BCG Lab Company Summary
7.5.2 Japan BCG Lab Business Overview
7.5.3 Japan BCG Lab Tuberculosis Vaccines Major Product Offerings
7.5.4 Japan BCG Lab Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Japan BCG Lab Key News & Latest Developments
7.6 IDT Biologics
7.6.1 IDT Biologics Company Summary
7.6.2 IDT Biologics Business Overview
7.6.3 IDT Biologics Tuberculosis Vaccines Major Product Offerings
7.6.4 IDT Biologics Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 IDT Biologics Key News & Latest Developments
7.7 GreenSignal Bio Pharma
7.7.1 GreenSignal Bio Pharma Company Summary
7.7.2 GreenSignal Bio Pharma Business Overview
7.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Major Product Offerings
7.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 GreenSignal Bio Pharma Key News & Latest Developments
7.8 Taj Pharmaceuticals
7.8.1 Taj Pharmaceuticals Company Summary
7.8.2 Taj Pharmaceuticals Business Overview
7.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Major Product Offerings
7.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Taj Pharmaceuticals Key News & Latest Developments
7.9 Bavarian Nordic
7.9.1 Bavarian Nordic Company Summary
7.9.2 Bavarian Nordic Business Overview
7.9.3 Bavarian Nordic Tuberculosis Vaccines Major Product Offerings
7.9.4 Bavarian Nordic Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Bavarian Nordic Key News & Latest Developments
7.10 China National Biotec Group
7.10.1 China National Biotec Group Company Summary
7.10.2 China National Biotec Group Business Overview
7.10.3 China National Biotec Group Tuberculosis Vaccines Major Product Offerings
7.10.4 China National Biotec Group Tuberculosis Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 China National Biotec Group Key News & Latest Developments
8 Global Tuberculosis Vaccines Production Capacity, Analysis
8.1 Global Tuberculosis Vaccines Production Capacity, 2018-2029
8.2 Tuberculosis Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Tuberculosis Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tuberculosis Vaccines Supply Chain Analysis
10.1 Tuberculosis Vaccines Industry Value Chain
10.2 Tuberculosis Vaccines Upstream Market
10.3 Tuberculosis Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tuberculosis Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Tuberculosis Vaccines in Global Market
Table 2. Top Tuberculosis Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Tuberculosis Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Tuberculosis Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Tuberculosis Vaccines Sales by Companies, (K Doses), 2018-2023
Table 6. Global Tuberculosis Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Tuberculosis Vaccines Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Tuberculosis Vaccines Product Type
Table 9. List of Global Tier 1 Tuberculosis Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tuberculosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Tuberculosis Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Tuberculosis Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Tuberculosis Vaccines Sales (K Doses), 2018-2023
Table 15. By Type - Global Tuberculosis Vaccines Sales (K Doses), 2024-2029
Table 16. By Application ? Global Tuberculosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Tuberculosis Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Tuberculosis Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Tuberculosis Vaccines Sales (K Doses), 2018-2023
Table 20. By Application - Global Tuberculosis Vaccines Sales (K Doses), 2024-2029
Table 21. By Region ? Global Tuberculosis Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Tuberculosis Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Tuberculosis Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Tuberculosis Vaccines Sales (K Doses), 2018-2023
Table 25. By Region - Global Tuberculosis Vaccines Sales (K Doses), 2024-2029
Table 26. By Country - North America Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Tuberculosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Tuberculosis Vaccines Sales, (K Doses), 2018-2023
Table 29. By Country - North America Tuberculosis Vaccines Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Tuberculosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Tuberculosis Vaccines Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Tuberculosis Vaccines Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Tuberculosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Tuberculosis Vaccines Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Tuberculosis Vaccines Sales, (K Doses), 2024-2029
Table 38. By Country - South America Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Tuberculosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Tuberculosis Vaccines Sales, (K Doses), 2018-2023
Table 41. By Country - South America Tuberculosis Vaccines Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Tuberculosis Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Tuberculosis Vaccines Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Tuberculosis Vaccines Sales, (K Doses), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Tuberculosis Vaccines Product Offerings
Table 48. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Tuberculosis Vaccines Product Offerings
Table 52. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Serum Institute of India Company Summary
Table 55. Serum Institute of India Tuberculosis Vaccines Product Offerings
Table 56. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Serum Institute of India Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Tuberculosis Vaccines Product Offerings
Table 60. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Japan BCG Lab Company Summary
Table 63. Japan BCG Lab Tuberculosis Vaccines Product Offerings
Table 64. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Japan BCG Lab Key News & Latest Developments
Table 66. IDT Biologics Company Summary
Table 67. IDT Biologics Tuberculosis Vaccines Product Offerings
Table 68. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. IDT Biologics Key News & Latest Developments
Table 70. GreenSignal Bio Pharma Company Summary
Table 71. GreenSignal Bio Pharma Tuberculosis Vaccines Product Offerings
Table 72. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. GreenSignal Bio Pharma Key News & Latest Developments
Table 74. Taj Pharmaceuticals Company Summary
Table 75. Taj Pharmaceuticals Tuberculosis Vaccines Product Offerings
Table 76. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Taj Pharmaceuticals Key News & Latest Developments
Table 78. Bavarian Nordic Company Summary
Table 79. Bavarian Nordic Tuberculosis Vaccines Product Offerings
Table 80. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. Bavarian Nordic Key News & Latest Developments
Table 82. China National Biotec Group Company Summary
Table 83. China National Biotec Group Tuberculosis Vaccines Product Offerings
Table 84. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. China National Biotec Group Key News & Latest Developments
Table 86. Tuberculosis Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 87. Global Tuberculosis Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Tuberculosis Vaccines Production by Region, 2018-2023 (K Doses)
Table 89. Global Tuberculosis Vaccines Production by Region, 2024-2029 (K Doses)
Table 90. Tuberculosis Vaccines Market Opportunities & Trends in Global Market
Table 91. Tuberculosis Vaccines Market Drivers in Global Market
Table 92. Tuberculosis Vaccines Market Restraints in Global Market
Table 93. Tuberculosis Vaccines Raw Materials
Table 94. Tuberculosis Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical Tuberculosis Vaccines Downstream
Table 96. Tuberculosis Vaccines Downstream Clients in Global Market
Table 97. Tuberculosis Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tuberculosis Vaccines Segment by Type in 2022
Figure 2. Tuberculosis Vaccines Segment by Application in 2022
Figure 3. Global Tuberculosis Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Tuberculosis Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Tuberculosis Vaccines Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Tuberculosis Vaccines Revenue in 2022
Figure 9. By Type - Global Tuberculosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Tuberculosis Vaccines Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Tuberculosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Tuberculosis Vaccines Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Tuberculosis Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Tuberculosis Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 23. US Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 37. China Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Tuberculosis Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Tuberculosis Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Tuberculosis Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Tuberculosis Vaccines Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Tuberculosis Vaccines by Region, 2022 VS 2029
Figure 54. Tuberculosis Vaccines Industry Value Chain
Figure 55. Marketing Channels
